0.11 | 0.56%
| Price and Volume | |
|---|---|
| Recent Price | 19.79 |
| 52 Week High | 23.00 |
| 52 Week Low | 8.84 |
| Avg. Daily Vol. (Mil) | 0.08 |
| Beta (3 year) | 1.69 |
| Share Related Items | |
| Mkt Cap (Mil) | 191.14 |
| Shares Out (Mil) | 12.60 |
| Float (Mil) | 8.37 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 2.50 |
| Current Ratio | 3.50 |
| LT Debt/ Equity | 0.01 |
| Total Debt / Equity | 0.01 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 2.03 |
| Price/Book | 2.05 |
| Price/Cash Flow | 35.70 |
| Per Share Data | |
| Earnings | -0.01 |
| Sales | 9.75 |
| Book Value | 9.66 |
| Cash Flow | 0.55 |
| Business Summary | |
|---|---|
| Cynosure, Inc. develops and markets aesthetic treatment systems used by physicians and other practitioners that incorporate laser and light-based energy sources. | |
| General Information | |
| 5 Carlisle Road
Westford, MA 01886 |
|
| www.cynosurelaser.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 346 | |
| CEO: Michael R. Davin | |
| Short Interest | |
| Current Month (Mil) | 0.39 |
| Previous Month (Mil) | 0.39 |
| Short Interest Ratio (Days) | 3.20 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -0.10 |
| Return on Investments | -0.20 |
| Profitability | |
| Gross Margin | 61.60 |
| EBIT Margin | 0.50 |
| Profit Margin | -0.20 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,524.42 | 1,326.11 | 2,855.25 | 17.16 |
Oil *
106.83
|
|
UP
69.59 |
UP
8.29 |
UP
17.72 |
DOWN
0.29 |
10 Yr
1.72%
SPDR Gold
150.76
|
|
+0.56%
|
+0.63%
|
+0.62%
|
-1.66%
|
Data delayed 20 minutes |
Connect with TheStreet